PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0085681|hyperphosphatemia |
| Sentences | 5 |
| PubMedID- 23740131 | Background: hyperphosphatemia is associated with cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 23364583 | Vascular dysfunction characterized by endothelial-cell damage, inflammation, and impaired angiogenesis is described in ckd, and hyperphosphatemia has been associated with vascular disease in ckd and general populations. |
| PubMedID- 21567407 | hyperphosphatemia is associated with ectopic calcification, cardiovascular disease, and increased mortality in patients with chronic kidney disease (ckd). |
| PubMedID- 20944546 | Vascular calcification, which contributes to cardiovascular disease in patients with uremic hyperphosphatemia, is associated with vascular cell expression of osteogenic genes, including bone morphogenetic protein (bmp)-2 and osteopontin (opn). |
| PubMedID- 25629999 | The association between hyperphosphatemia and increased risk of death from cardiovascular disease/vascular calcification has been well established for a long time. |
Page: 1